Amygdalar Calcitonin Gene-Related Peptide Driven Effects of Cold Sensitivity Induced by Peripheral Neuropathy in Mice
Preprint
Abstract
The central nucleus of the amygdala (CeA) is a critical regulator of nociception, and its role in pain modulation depends on factors such as hemispheric location, neuropeptide release, and experimental model. Calcitonin gene-related peptide (CGRP) is a potent neuropeptide modulator within the CeA. Previous research has demonstrated its CeA nociceptive role in migraine, visceral, arthritic, and inflammatory pain murine models. The contribution of CeA CGRP to neuropathic pain is unclear. This study examined the effects of CGRP and its receptor antagonist, CGRP 8-37, in the CeA on mechanical and cold sensitivity in two mouse models of neuropathic pain: chemotherapy-induced peripheral neuropathy (CIPN) mediated by paclitaxel (PTX) and injury-induced neuropathy through the spared nerve injury (SNI) model. Mechanical and cold sensitivity were measured using the hindpaw von Frey and topical acetone drop assays, respectively. Neither CGRP nor CGRP 8-37 in the CeA had any significant effect on mechanical sensitivity in either neuropathic pain model. In the SNI-treated mice, CGRP infusion into either the left or right CeA reduced cold sensitivity in the left and right SNI-treated hindpaw, while CGRP 8-37 infusion into the left or right CeA increased cold sensitivity in the right SNI-treated hindpaw only. In PTX-treated mice, CGRP infusion into the left or right CeA decreased cold sensitivity of the contralateral paw only. These results suggest that CGRP in the CeA influences pain modulation in a complex manner that depends not only on the hemisphere and injury site, but also on the underlying cause of the neuropathic condition. PERSPECTIVE This article presents the anti-nociceptive properties of calcitonin gene-related peptide (CGRP) signaling within the central nucleus of the amygdala during neuropathic pain-like conditions in mice. This dataset can serve to guide novel drug development for treating chronic neuropathic pain conditions. Lateralization of the central nucleus of the amygdala (CeA) is pain-model dependent CGRP signaling within the CeA is correlated with decreased cold sensitivity Different neuropathic etiologies yield differences in CGRP responsivenessKeywords
All Related Versions
- Published version: The Journal of Pain, 41, 106199.
This publication has 71 references indexed in Scilit:
- A Parabrachial-to-Amygdala Circuit That Determines Hemispheric Lateralization of Somatosensory ProcessingBiological Psychiatry, 2022
- The central nucleus of the amygdala lesion attenuates orthodontic pain during experimental tooth movement in ratsBrain and Behavior, 2019
- Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal–Regulated Kinase Signaling Regulates the Emotional Component of PainBiological Psychiatry, 2017
- The amygdala central nucleus is required for acute stress-induced bladder hyperalgesia in a rat visceral pain modelBrain Research, 2015
- Calcitonin gene-related peptide-containing pathways in the rat forebrainJournal of Comparative Neurology, 2005
- Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in ratsBrain Research, 2004
- The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin testPain, 1995
- The distribution of systemically administered [3H]-paclitaxel in rats: a quantitative autoradiographic studyCancer Chemotherapy and Pharmacology, 1995
- Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic painPain, 1994
- Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric autonomic neurons of the ratNeuroscience, 1988